Results 11 to 20 of about 506,905 (306)

The impact of COVID-19 on the tuberculosis control activities in Addis Ababa

The Pan African Medical Journal, 2021
The first COVID-19 case was reported in Ethiopia on 13th March 2020 and series of announcements of set of measures, proclamation and directives have been enacted to fight the coronavirus pandemic.
Negussie Wodajo Beyene, Alemu Lakew Sitotaw, Ben Tegegn, Kidist Bobosha   +3 more
doaj   +1 more source

Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013–2018

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2021
Background: In 2019, the World Health Organization released guidelines reflecting major changes in multidrug-resistant tuberculosis (MDR-TB) management—prioritizing fluoroquinolones, bedaquiline, and linezolid (LZD) while de-emphasizing previously ...
Ashley McDowell, Michelle Haas, Barbara Seaworth, John W. Wilson, Amee Patrawalla, Connie Haley, Mike Lauzardo, Miko de Bruyn, Neela D. Goswami   +8 more
doaj   +1 more source

Optimal drug synergy in antimicrobial treatments. [PDF]

PLoS Computational Biology, 2010
The rapid proliferation of antibiotic-resistant pathogens has spurred the use of drug combinations to maintain clinical efficacy and combat the evolution of resistance.
Joseph Peter Torella, Remy Chait, Roy Kishony   +2 more
doaj   +1 more source

Drug Resistance Reversal Potential of Nanoparticles/Nanocomposites via Antibiotic’s Potentiation in Multi Drug Resistant P. aeruginosa

Nanomaterials, 2021
Bacteria employ numerous resistance mechanisms against structurally distinct drugs by the process of multidrug resistance. A study was planned to discover the antibacterial potential of a graphene oxide nanosheet (GO), a graphene oxide–zinc oxide ...
Pratima Pandey, Rajashree Sahoo, Khusbu Singh, Sanghamitra Pati, Jose Mathew, Avinash Chandra Pandey, Rajni Kant, Ihn Han, Eun-Ha Choi, Gaurav Raj Dwivedi, Dharmendra K. Yadav   +10 more
doaj   +1 more source

Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance [PDF]

, 2004
Drug-resistant tuberculosis can be transmitted (primary) or develop during the course of treatment (secondary). We investigated risk factors for each type of resistance.
Glynn, JR, Story, A, Hayward, AC, Watson, JM, Conaty, SJ, Drobniewski, FA   +5 more
core   +1 more source

Multi drug resistant tuberculosis

The Indian Journal of Pediatrics, 1996
The prevalence of multi-drug resistant tuberculosis is increasing globally which has upset tuberculosis treatment and control programmes. The problem has been further complicated by co-infection with HIV virus. Treatment of multi drug resistant tuberculosis is difficult, expensive and requires long duration chemotherapy. The long term prognosis is poor
A B, Dey, K, Nagarkar
openaire   +4 more sources

Effect of Anti-Tuberculosis Multi Drug Resistance Regimen on Hematological Lung Tuberculosis Patients Profile with Multi Drug Resistance

Berkala Kedokteran, 2018
: ATD administration of tuberculosis in combination and duration often causes multi drug resistance (MDR) ATD due to discontinuation of treatment. Reported hematologic abnormal changes due to ATD.
Pradana Maulana Putra
doaj   +1 more source

The evolution of resistance to synergistic multi‐drug combinations is more complex than evolving resistance to each individual drug component

Evolutionary Applications, 2023
Multidrug antibiotic resistance is an urgent public health concern. Multiple strategies have been suggested to alleviate this problem, including the use of antibiotic combinations and cyclic therapies.
Natalie Ann Lozano‐Huntelman, Austin Bullivant, Jonathan Chacon‐Barahona, Alondra Valencia, Nick Ida, April Zhou, Pooneh Kalhori, Gladys Bello, Carolyn Xue, Sada Boyd, Colin Kremer, Pamela J. Yeh   +11 more
doaj   +1 more source

Multi-drug resistance patterns of bacterial isolates.

, 2022
Multi-drug resistance patterns of bacterial isolates.
Belay Tessema (3181893), Muluneh Assefa (12029676), Teshome Belachew (5467643), Abiye Tigabu (6828890)   +3 more
core   +1 more source

Molecular monitoring of HIV-1 drug resistance in Ifakara HIV-1 Cohort, Tanzania [PDF]

, 2013
HIV-1 resistance is one of the problems affecting success of antiretroviral therapy programmes worldwide. Many studies on efficacy of ART programmes, specifically on drug resistance, have been conducted in developed countries but not in developing ...
Masimba, Pax Jessey
core   +1 more source